ERBB2 and invasive ductal breast carcinoma: Of all patients, most patients had tumors categorized as T1(79.4%), ER positive (75.9%), HER-2 negative (88.7%), LVI negative (89.5%), Grade I-II (60.6%) and histologic type of invasive ductal carcinoma (IDC,87.3%).